Literature DB >> 22130358

The impact of obesity on urinary tract infection risk.

Michelle J Semins1, Andrew D Shore, Martin A Makary, Jonathan Weiner, Brian R Matlaga.   

Abstract

OBJECTIVE: To perform a study to describe the way in which an increasingly obese body mass index (BMI) is associated with urinary tract infection (UTI). The association between UTI and obesity is not well characterized. In fact, previous investigations of this subject have yielded conflicting findings. UTI is increasingly being recognized as a preventable complication, and UTI rates are used to measure quality of surgical care.
MATERIALS AND METHODS: We evaluated claims over a 5-year period (2002-2006) in a national private claims database to identify patients diagnosed with UTI or pyelonephritis by ICD-9 coding. Descriptive analyses were performed and odds ratios were calculated.
RESULTS: A total of 95,598 subjects were identified for evaluation. Gender distribution was 42.9% male and 57.1% female. In the overall study cohort, the diagnosis of a UTI or pyelonephritis occurred in 13% and 0.84%, respectively. Women were 4.2 times more likely to be diagnosed with a UTI (19.3% vs 4.6%), and 3.6 times more likely to be diagnosed with pyelonephritis (1.22% vs 0.34%), than were men. At all stratifications of obesity, the obese were significantly more likely to be diagnosed with a UTI or pyelonephritis than nonobese patients.
CONCLUSION: Elevated BMI appears to be associated with an increased risk for UTI and pyelonephritis. Further study is needed to determine whether this association may be attributed to a cause-and-effect relationship. However, these results may serve to guide clinicians who treat obese patients, because it may be an additional benefit of weight loss.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22130358     DOI: 10.1016/j.urology.2011.09.040

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  35 in total

1.  Predictors of Postoperative Urinary Tract Infection After Bariatric Surgery.

Authors:  Zachary M Helmen; Melissa C Helm; Joseph H Helm; Alexander Nielsen; Tammy Kindel; Rana Higgins; Jon C Gould
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

2.  Indwelling catheterization, renal stones, and hydronephrosis are risk factors for symptomatic Staphylococcus aureus-related urinary tract infection.

Authors:  Hiroyuki Kitano; Norifumi Shigemoto; Yumiko Koba; Toshinori Hara; Kashiyama Seiya; Keitaro Omori; Katsumi Shigemura; Jun Teishima; Masato Fujisawa; Akio Matsubara; Hiroki Ohge
Journal:  World J Urol       Date:  2020-05-03       Impact factor: 4.226

3.  Impact of Obesity on Urinary Tract Infections in Korean Adults: Secondary Data Analysis Using Community-Based Cohort Study.

Authors:  Seung Hee Seo; Ihn Sook Jeong; Eun Joo Lee
Journal:  J Korean Acad Nurs       Date:  2021-04       Impact factor: 0.984

4.  Increased Risk of Bacterial Infections among the Obese with Chronic Diseases.

Authors:  Y Wang; Y Chen
Journal:  J Nutr Health Aging       Date:  2015-05       Impact factor: 4.075

Review 5.  Association between body mass index and urinary tract infection: a systematic review and meta-analysis of observational cohort studies.

Authors:  Habeeb Alhabeeb; Saeed Baradwan; Hamed Kord-Varkaneh; Shing Cheng Tan; Teck Yew Low; Osama Alomar; Hany Salem; Ismail Abdulrahman Al-Badawi; Ahmed Abu-Zaid
Journal:  Eat Weight Disord       Date:  2021-01-09       Impact factor: 4.652

Review 6.  Obesity: impact of infections and response to vaccines.

Authors:  C Tagliabue; N Principi; C Giavoli; S Esposito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-30       Impact factor: 3.267

7.  Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis.

Authors:  Karishma Gupta; Shannon B Donnola; Zhina Sadeghi; Lan Lu; Bernadette O Erokwu; Michael Kavran; Adonis Hijaz; Chris A Flask
Journal:  J Vis Exp       Date:  2017-07-18       Impact factor: 1.355

8.  Weight loss surgery improves the metabolic status in an obese rat model but does not affect bladder fibrosis associated with high fat diet feeding.

Authors:  A Oberbach; N Schlichting; M Heinrich; S Lehmann; H Till; F W Mohr; F Mannello; J-U Stolzenburg; J Neuhaus
Journal:  Int J Obes (Lond)       Date:  2013-10-29       Impact factor: 5.095

9.  D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial.

Authors:  Bojana Kranjčec; Dino Papeš; Silvio Altarac
Journal:  World J Urol       Date:  2013-04-30       Impact factor: 4.226

10.  Management of recurrent urinary tract infections in healthy adult women.

Authors:  Duane R Hickling; Victor W Nitti
Journal:  Rev Urol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.